Delivery Order SPE2DB20D1100-SPE2DB25FD9K7
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,228.37 on August 11, 2025, for the supply of TALTZ 80 MG/ML AutoInjector (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions and represents a routine pharmaceutical procurement through established federal...
- The Defense Logistics Agency awarded a $46,054.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Taltz 80 mg/mL auto-injector (2-pack) pharmaceutical product. The contract, which is set to be completed by August 1, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This competitively awarded delivery order represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. The contract is valued at $5,806.95 with a firm fixed price structure and an ultimate completion date of August 27, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,641.24 on August 20, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, non-set-aside contract with a completion date of August 21, 2025, and performance location in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework...
- The Defense Logistics Agency awarded a $22,134.58 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Taltz 80 mg/ml auto-injector two-packs, with a firm fixed price ceiling value of $46,869.29. This non-set-aside competitive award is classified as a delivery order with an ultimate completion date of August 12, 2025, and represents a continuation of the vendor's extensive pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of TALTZ 80 mg/ml auto-injector medication. This non-set-aside, competitively awarded contract carries a ceiling value of $6,641.24 under a firm fixed price arrangement, with an ultimate completion date of August 19, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TALTZ 80 mg/mL autoinjectors, valued at $7,187.24. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical supply chains, with performance to be fulfilled from the company's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of TALTZ 80 mg/ml auto-injector (2-pack) with a ceiling value of $9,029.13 under a firm fixed-price contract type. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999.9 million through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a $19,447.53 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of TALTZ 80 MG/ML auto-injector (2-pack) pharmaceutical products. This firm fixed-price delivery order, which concludes on August 15, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and a major...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9K7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Taltz 80 mg/ml auto-injector medication, with a ceiling value of $1,660.30. This firm fixed-price delivery order, which is scheduled for completion by August 11, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement. The award was made without a set-aside designation, indicating competitive award status. AmerisourceBergen's place of performance is based at its corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to fulfill diverse pharmaceutical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/8/25 |